MNTA: I am not second-guessing anyone, but, a year seems like a long period of time for such a commonly performed procedure. (Noting that this is a trial and not SOC, of course)
Also, "one year" may have been for final data and dissemination. All this investor wants is interim data. An excellent forum for such may be in March at the American College of Cardio.
Mass. General performs 600 of these in @ 3 months!
There is a dearth of MNTA information out there, other than the Company website.
I believe we are still waiting on the PI sub-Q data, as well.
Their Oct 11 PR mentioned that "over 100" patients had been dosed with M118 as of that date... which could have only included 1 or 2 PII patients. The IV PI dosed 36, so, we can deduce some quantity for the Sub-Q study.
"I guess."
Market Data 
Markets 
AI
